Merit Financial Group’s Revolution Medicines RVMD Stock Holding History

Merit Financial Group’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$709K	Buy	+3,787	New	+$553K	﹤0.01%	1283

Other funds holding RVMD

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SCA

Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Merit Financial Group's RVMD Position: Q2 2026 in Review

Merit Financial Group opened a new position in Revolution Medicines (RVMD) in Q2 2026: 3,787 shares worth $709K. The stake represents ﹤0.01% of the portfolio and ranks #1283 among its holdings.

107 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Merit Financial Group held 3,787 shares of Revolution Medicines worth $709K as of Q2 2026.
Revolution Medicines was a new Merit Financial Group position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1283 holding.
107 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.